129 related articles for article (PubMed ID: 12505710)
1. Cryopreservation of immature monocyte-derived dendritic cells results in enhanced cell maturation but reduced endocytic activity and efficiency of adenoviral transduction.
John J; Hutchinson J; Dalgleish A; Pandha H
J Immunol Methods; 2003 Jan; 272(1-2):35-48. PubMed ID: 12505710
[TBL] [Abstract][Full Text] [Related]
2. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.
Zobywalski A; Javorovic M; Frankenberger B; Pohla H; Kremmer E; Bigalke I; Schendel DJ
J Transl Med; 2007 Apr; 5():18. PubMed ID: 17430585
[TBL] [Abstract][Full Text] [Related]
3. Cryopreservation of adenovirus-transfected dendritic cells (DCs) for clinical use.
Gülen D; Maas S; Julius H; Warkentin P; Britton H; Younos I; Senesac J; Pirruccello SM; Talmadge JE
Int Immunopharmacol; 2012 May; 13(1):61-8. PubMed ID: 22465385
[TBL] [Abstract][Full Text] [Related]
4. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
5. Activation of monocytes via the CD14 receptor leads to the enhanced lentiviral transduction of immature dendritic cells.
Breckpot K; Corthals J; Heirman C; Bonehill A; Michiels A; Tuyaerts S; De Greef C; Thielemans K
Hum Gene Ther; 2004 Jun; 15(6):562-73. PubMed ID: 15212715
[TBL] [Abstract][Full Text] [Related]
6. Freeze-thawing procedures have no influence on the phenotypic and functional development of dendritic cells generated from peripheral blood CD14+ monocytes.
Hori S; Heike Y; Takei M; Maruyama M; Inoue Y; Lee JJ; Kim HJ; Harada Y; Kawai H; Shimosaka A; Kami M; Tanosaki MD; Wakasugi H; Saito S; Takaue Y; Kakizoe T
J Immunother; 2004; 27(1):27-35. PubMed ID: 14676631
[TBL] [Abstract][Full Text] [Related]
7. Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cells.
Nishimura N; Nishioka Y; Shinohara T; Sone S
Hum Gene Ther; 2001 Mar; 12(4):333-46. PubMed ID: 11242526
[TBL] [Abstract][Full Text] [Related]
8. A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines.
Mu LJ; Gaudernack G; Saebøe-Larssen S; Hammerstad H; Tierens A; Kvalheim G
Scand J Immunol; 2003 Nov; 58(5):578-86. PubMed ID: 14629630
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of using monocyte-derived dendritic cells obtained from cryopreserved cells for DC-based vaccines.
Usero L; Miralles L; Esteban I; Pastor-Quiñones C; Maleno MJ; Leal L; García F; Plana M
J Immunol Methods; 2021 Nov; 498():113133. PubMed ID: 34480950
[TBL] [Abstract][Full Text] [Related]
10. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
[TBL] [Abstract][Full Text] [Related]
11. A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use.
Feuerstein B; Berger TG; Maczek C; Röder C; Schreiner D; Hirsch U; Haendle I; Leisgang W; Glaser A; Kuss O; Diepgen TL; Schuler G; Schuler-Thurner B
J Immunol Methods; 2000 Nov; 245(1-2):15-29. PubMed ID: 11042280
[TBL] [Abstract][Full Text] [Related]
12. Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.
Nishimoto KP; Tseng SY; Lebkowski JS; Reddy A
Regen Med; 2011 May; 6(3):303-18. PubMed ID: 21548736
[TBL] [Abstract][Full Text] [Related]
13. Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors.
Gulen D; Abe F; Maas S; Reed E; Cowan K; Pirruccello S; Wisecarver J; Warkentin P; Northam M; Turken O; Coskun U; Senesac J; Talmadge JE
Int Immunopharmacol; 2008 Dec; 8(13-14):1728-36. PubMed ID: 18793758
[TBL] [Abstract][Full Text] [Related]
14. Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.
Schaft N; Dörrie J; Thumann P; Beck VE; Müller I; Schultz ES; Kämpgen E; Dieckmann D; Schuler G
J Immunol; 2005 Mar; 174(5):3087-97. PubMed ID: 15728524
[TBL] [Abstract][Full Text] [Related]
15. Cryopreservation of monocytes or differentiated immature DCs leads to an altered cytokine response to TLR agonists and microbial stimulation.
Meijerink M; Ulluwishewa D; Anderson RC; Wells JM
J Immunol Methods; 2011 Oct; 373(1-2):136-42. PubMed ID: 21878338
[TBL] [Abstract][Full Text] [Related]
16. Generation of dendritic cells from fresh and frozen cord blood CD34+ cells.
Sato K; Nagayama H; Takahashi TA
Cryobiology; 1998 Dec; 37(4):362-71. PubMed ID: 9917353
[TBL] [Abstract][Full Text] [Related]
17. Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10(high)IL-12absent dendritic cells with tolerogenic potential.
Li G; Kim YJ; Broxmeyer HE
J Immunol; 2005 Apr; 174(8):4706-17. PubMed ID: 15814695
[TBL] [Abstract][Full Text] [Related]
18. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
[TBL] [Abstract][Full Text] [Related]
19. Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma Patients.
Nava S; Lisini D; Pogliani S; Dossena M; Bersano A; Pellegatta S; Parati E; Finocchiaro G; Frigerio S
Stem Cells Transl Med; 2015 Oct; 4(10):1164-72. PubMed ID: 26273063
[TBL] [Abstract][Full Text] [Related]
20. Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacity.
Ye Z; Chen Z; Sami A; El-Gayed A; Xiang J
Cancer Biother Radiopharm; 2006 Dec; 21(6):613-22. PubMed ID: 17257077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
